Prevalence and
distribution of CAD, CVBD, PAOD
Abdominal
aortic calcification in dialysis patients
Target ranges
of biochemistries of secondary
HPT in CKD
Serum phosphate
and survival
Calciphylaxis
Overview of therapeutic options and impact for secondary HPT
Recognition of various P binders
Beneficial
effects of calcimimetics on bone, parathyroid, and vessel cells
Figure
link (cinacalcet and etelcalcetide)
When to initiate calcimimetics
treatment
Cardiovascular disease and CKD: AJKD core curriculum
2010
Why CVD in CKD
so many? (Traditional and Nontraditional CV Risk Factors)
Survival markers
in dialysis patients
1. Albumin
2. hs-CRP, paper link figure link
3. Cardiovascular
disease
